Showing 1 - 15 results of 15 for search 'Chengcheng Gong', query time: 0.05s
Refine Results
-
1
-
2
-
3
-
4
Clinicopathological characteristics, evolution, treatment pattern and outcomes of hormone-receptor-positive/HER2-low metastatic breast cancer by Shuhui You, Shuhui You, Chengcheng Gong, Chengcheng Gong, Yi Li, Yizhao Xie, Yumeng Li, Yumeng Li, Yannan Zhao, Yannan Zhao, Biyun Wang, Biyun Wang
Published 2023-10-01
Article -
5
Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2− Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study by Yannan Zhao, Cheng Liu, Yingjian Zhang, Chengcheng Gong, Yi Li, Yizhao Xie, Bingrui Wu, Zhongyi Yang, Biyun Wang
Published 2018-09-01
Article -
6
A multicenter analysis of treatment patterns and clinical outcomes of subsequent therapies after progression on palbociclib in HR+/HER2− metastatic breast cancer by Yi Li, Wei Li, Chengcheng Gong, Yabin Zheng, Quchang Ouyang, Ning Xie, Qing Qu, Rui Ge, Biyun Wang
Published 2021-06-01
Article -
7
DNA methylation suppresses chitin degradation and promotes the wing development by inhibiting Bmara-mediated chitinase expression in the silkworm, Bombyx mori by Guanfeng Xu, Yangqin Yi, Hao Lyu, Chengcheng Gong, Qili Feng, Qisheng Song, Xuezhen Peng, Lin Liu, Sichun Zheng
Published 2020-09-01
Article -
8
-
9
Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study by Yi Li, Chengcheng Gong, Qianyi Lu, Zhaochun Zhou, Ting Luo, Wei Li, Gang Li, Rui Ge, Fei Xu, Biyun Wang
Published 2020-03-01
Article -
10
ER status conversion and subsequent treatment: an assessment of negative ER expression detected by 18F-FES PET in metastatic breast cancer patients with ER-positive primary tumors by Shuhui You, Yizhao Xie, Mengjing Ji, Cheng Liu, Yannan Zhao, Chengcheng Gong, Shihui Hu, Yumeng Li, Zhongyi Yang, Biyun Wang
Published 2023-12-01
Article -
11
Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score–matched analysis of real-world data by Chengcheng Gong, Yizhao Xie, Yannan Zhao, Yi Li, Jian Zhang, Leiping Wang, Jun Cao, Zhonghua Tao, Xichun Hu, Biyun Wang
Published 2022-12-01
Article -
12
Chemotherapy Shows a Better Efficacy Than Endocrine Therapy in Metastatic Breast Cancer Patients with a Heterogeneous Estrogen Receptor Expression Assessed by <sup>18</sup>F-FES PE... by Yizhao Xie, Xinyue Du, Yannan Zhao, Chengcheng Gong, Shihui Hu, Shuhui You, Shaoli Song, Xichun Hu, Zhongyi Yang, Biyun Wang
Published 2022-07-01
Article -
13
-
14
Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of <sup>18</sup>F-FDG Uptake Predicts Treatment Outcome of Pyrotinib in Patients with HER2-Positive Metastatic B... by Chengcheng Gong, Cheng Liu, Zhonghua Tao, Jian Zhang, Leiping Wang, Jun Cao, Yannan Zhao, Yizhao Xie, Xichun Hu, Zhongyi Yang, Biyun Wang
Published 2022-08-01
Article -
15
Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases by Yizhao Xie, Chengcheng Gong, Jian Zhang, Leiping Wang, Jun Cao, Zhonghua Tao, Ting Li, Yannan Zhao, Yi Li, Shihui Hu, Biyun Wang, Xichun Hu
Published 2021-11-01
Article